Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Effect of Dimethyl Fumarate Administered to Patients With Adrenomyeloneuropathy: a Multicenter, Placebo Controlled, Phase IIb/III Trial

NCT06513533 is registered in ClinicalTrials.gov with Pujol, Aurora, M.D. as lead sponsor.

NCT NCT06513533
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06513533 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Effect of Dimethyl Fumarate Administered to Patients With Adrenomyeloneuropathy: a Multicenter, Placebo Controlled, Phase IIb/III Trial
Lead sponsor
Pujol, Aurora, M.D.
Phase
Phase 2/3
Overall status
Active, not recruiting
Start date
April 23, 2024
Completion date
June 30, 2028
Enrollment
40 (estimated)
Sites
3

Conditions

As the registry lists them; a condition with its own page is linked.

adrenomyeloneuropathy without cerebral involvement